Valeant Pharmaceuticals International (VRX) · page 28 of 47
The table models four scenarios based on annual M&A spend ($0bn, $5bn, $10bn, $20bn).
Conference presentation · scenario_table · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/6
callout 3/3 metric 0/1 table 1/1 title 1/1
1 without position metric 1
metric · primary
Components 6
primary primary primary primary scenario headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1